What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Enterprise Value?

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Enterprise Value is $2.3M, based on as-reported figures from SEC (XBRL) filings.

What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Net Income (TTM)?

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Net Income (TTM) is -$1.1M, based on as-reported figures from SEC (XBRL) filings.

What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Diluted EPS (TTM)?

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Diluted EPS (TTM) is -0.07, based on as-reported figures from SEC (XBRL) filings.

What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA Margin?

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA Margin is -17.2%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares

XNAS · usd

SIC 5122 · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

FIGI AK-46976230C7

0.10▲ 0.00 (4.17%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 0.10
Day's Range: 0.09 – 0.11
52-Week Range: 0.08 – 1.72
Volume: 1.2M
Avg Volume: 1.3M

Share Statistics

Shares Outstanding
Employees: 27
Exchange: XNAS
Listed: 2025-01-15

Share count as of March 31, 2026

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Cellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD)

What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Market Cap?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Market Cap is $1.6M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Enterprise Value?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Enterprise Value is $2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Price / Sales?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Price / Sales is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EV / Revenue?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EV / Revenue is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EV / EBITDA?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Revenue (TTM)?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Revenue (TTM) is $13.4M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Net Income (TTM)?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Net Income (TTM) is -$1.1M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA is -$2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Diluted EPS (TTM)?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Diluted EPS (TTM) is -0.07, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA Margin?: Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA Margin is -17.2%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · HKPDAs-filed SEC (XBRL) data